Technology | November 24, 2014

EDDA Technology Introduces IQQA-BodyImaging and Cloud-Based OnDemand Services for Imaging-Guided Cancer Treatment

IQQA-BodyImaging extends product suite features to thoracic, abdominal and pelvic applications of cancer treatment planning

November 24, 2014 — EDDA Technology announced that the company has received U.S. Food and Drug Administration (FDA) clearance on IQQA-BodyImaging. The new product will be introduced as the latest addition to the IQQA Platform and Product Suite for imaging-guided cancer treatment at the 100th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago IL Nov. 30-Dec. 5. Also being introduced at RSNA is the company’s cloud-based OnDemand service with its clinical collaborator Massachusetts General Hospital.

The IQQA Platform and Product Suite was developed with a specific aim to maximize the utilization of multimodality imaging and its benefit for multiple stakeholders along the cycle of patient care, which include radiologists, interventional radiologists, surgeons and oncologists. By supporting efficient collaboration for optimal workflow and treatment management with clinical depth and OnDemand accessibility, the IQQA Platform enables a patient-specific, disease-targeted and multidisciplinary approach to cancer treatment.

The IQQA-BodyImaging extends the 3-D features found in the IQQA product portfolio to thoracic, abdominal and pelvic multimodality scans. Features such as virtual knife for surgery and virtual needle for interventional procedural planning, monitoring and follow-up, provide comprehensive tools for tumor board assessment.

The company will also be demonstrating IQQA-Liver Multimodality, as part of the IQQA Product Suite. IQQA-Liver Multimodality is currently being used by physicians worldwide for real-time, interactive treatment planning and post-procedural assessment of liver diseases.

Through its proprietary IQQA Web-enabling technology and clinical partnership, EDDA offers OnDemand services for practices to use IQQA applications anytime and anywhere. “Through a combination of technology and in-depth clinical expertise, the MGH 3D Imaging Service offers access to our team of dedicated 3-D technologists to other hospitals and imaging centers with the goal of improving patient care by enhancing the efficiency, reliability, and scalability of 3-D imaging solutions for clinical decision support,” said Gordon J. Harris, Ph.D., director of the 3-D Imaging Service at Massachusetts General Hospital.

The IQQA Product Suite also includes IQQA-Guide (work-in-progress) for intraoperative 3-D navigation, IQQA-LiverFunction (work-in-progress) for localized hepatic functional analysis using 3-D SPECT, and IQQA-Chest CAD for small lung nodule detection. EDDA will exhibit its IQQA Platform and Product Suite in booth #4571 at RSNA 2014.

For more information: www.eddatech.com

Related Content

Carestream dose management
Sponsored Content | Whitepapers | Advanced Visualization | August 17, 2017
It's critical for today's healthcare professionals to understand the balance between the risks and benefits of any X-...
Carestream Launches MR Brain Perfusion and Diffusion Modules for Vue PACS
Technology | Advanced Visualization | August 16, 2017
Carestream Health recently introduced new MR (magnetic resonance) Brain Perfusion and MR Brain Diffusion modules that...
CDN to Integrate Advanced Cardiac Imaging Tools From DiA Imaging Analysis
Technology | Advanced Visualization | August 10, 2017
August 10, 2017 — CDN recently announced a new partnership agreement with DiA Imaging Analysis Ltd., makers of next-g
GE Additive and Stryker Announce Additive Manufacturing Partnership
News | 3-D Printing | July 06, 2017
July 6, 2017 — GE Additive and Stryker have entered a partnership agreement to support Stryker’s growth in...
News | Procedure Navigation Systems | July 06, 2017
The U.S. Food and Drug Administration (FDA) recently issued a safety communication alerting healthcare providers about...
Philips Receives FDA 510(k) Clearance for IntelliSpace Portal 9.0
Technology | Advanced Visualization | June 29, 2017
Philips announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market...
Strain Imaging Improves Cardiac Surveillance of Certain Breast Cancer Patients
News | Cardio-oncology | May 03, 2017
Epsilon Imaging Inc. announced a research study using EchoInsight was presented at the American College of Cardiology (...
Fovia and Predible Health Combine XStream HDVR with Deep Learning to Fight Cancer
News | Advanced Visualization | April 25, 2017
Fovia Inc. and Predible Health announced a new collaboration to combine high-quality imaging performance and accuracy...
SyntheticMR Myelination Quantification Feature Receives CE Mark
News | Magnetic Resonance Imaging (MRI) | April 19, 2017
April 19, 2017 — REMyDI (Rapid Estimation of Myelin for Diagnostic Imaging), first introduced by SyntheticMR AB at th
3-D-printed Model of Stenotic Intracranial Artery Enables Vessel-Wall MRI Standardization
News | 3-D Printing | April 18, 2017
April 18, 2017 — A collaboration between stroke neurologists at the Medical University of South Carolina (MUSC) and b
Overlay Init